| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMRT | Class A Common Stock | Sale | -$265K | -51.4K | -0.26% | $5.16 | 19.8M | Aug 9, 2022 | See footnotes | F1, F2, F3, F4 |
| transaction | SMRT | Class A Common Stock | Sale | -$370K | -66.9K | -0.34% | $5.53 | 19.7M | Aug 10, 2022 | See footnotes | F1, F2, F3, F5 |
| transaction | SMRT | Class A Common Stock | Sale | -$536K | -95.6K | -0.48% | $5.61 | 19.6M | Aug 11, 2022 | See footnotes | F1, F2, F3, F6 |
Bain Capital Venture Investors, Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Bain Capital Venture Investors, LLC ("BCVI") is the manager of Bain Capital Venture Investors 2019, LLC ("BCVI 2019"), which is the general partner of each of Bain Capital Venture Fund 2019, L.P. ("BCV Fund 2019") and BCV 2019-MD Primary, L.P. ("BCV MD Primary"). As a result, BCVI 2019 may be deemed to share voting and dispositive power with respect to the shares of the Issuer's Class A Common Stock held by BCV Fund 2019 and BCV MD Primary. BCVI 2019 disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On August 9, 2022, August 10, 2022 and August 11, 2022, BCV Fund 2019 sold 44,756, 58,285 and 83,271 shares of the Issuer's Class A Common Stock, respectively, and BCV MD Primary sold 1,721, 2,242 and 3,203 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCV Fund 2019 and BCV MD Primary held 17,092,976 and 657,429 shares of the Issuer's Class A Common Stock, respectively. |
| F2 | Boylston Coinvestors, LLC is the general partner of each of BCIP Venture Associates II, L.P. ("BCIP Venture II") and BCIP Venture Associates II-B, LP ("BCIP Venture II-B" and, together with BCV Fund 2019, BCV MD Primary and BCIP Venture II, the "Bain Capital Venture Entities"). On August 9, 2022, August 10, 2022 and August 11, 2022, BCIP Venture II sold 4,553, 5,930 and 8,472 shares of the Issuer's Class A Common Stock, respectively, and BCIP Venture II-B sold 370, 482 and 688 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCIP Venture II and BCIP Venture II-B held 1,738,946 and 141,273 shares of the Issuer's Class A Common Stock, respectively. |
| F3 | The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Venture Entities is directed by the Executive Committee of BCVI, which consists of Enrique Salem and Ajay Agarwal. As a result, BCVI and Messrs. Salem and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Venture Entities. BCVI and Messrs. Salem and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.05 to $5.35, inclusive. The reporting persons undertake to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4. |
| F5 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.34 to $5.61, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.52 to $5.81, inclusive. |